Description
Mortality amongst Illicit Drug Users
Epidemiology, Causes and Intervention
International Research Monographs in the Addictions Series
Authors: Darke Shane, Degenhardt Louisa, Mattick Richard
This book is a synthetic review of the epidemiology, causes, prevalence, interventions, demography, and associated risk factors of illicit-drug-related mortality.
Language: EnglishSubject for Mortality amongst Illicit Drug Users:
Approximative price 62.44 €
In Print (Delivery period: 14 days).
Add to cart the print on demand of Darke Shane, Degenhardt Louisa, Mattick Richard
Mortality amongst Illicit Drug Users
Publication date: 08-2012
Support: Print on demand
Publication date: 08-2012
Support: Print on demand
Approximative price 131.09 €
Subject to availability at the publisher.
Add to cart the book of Darke Shane, Degenhardt Louisa, Mattick Richard
Mortality amongst illicit drug users: epidemiology, causes and intervention
Publication date: 09-2006
204 p. · 15.7x23.5 cm · Hardback
Publication date: 09-2006
204 p. · 15.7x23.5 cm · Hardback
Description
/li>Contents
/li>
Over the past 40 years the rate of illicit drug use worldwide has risen dramatically, and with it the number of deaths reported among drug-using populations. What are the clinical, ethical and psychopathological implications of these deaths? In this book, Shane Darke and his team provide the first full, synthetic review of the epidemiology, causes, prevalence, demography, and associated risk factors of illicit-drug-related mortality. In addition, they examine and evaluate interventions to reduce these deaths. The major causes of death among illicit drug users are overdose, disease, suicide and trauma. Each is independently examined. This is an important book for all clinicians and policy-makers involved in issues relating to illicit drug use.
1. Why illicit drug-related deaths matter; 2. The global epidemiology of illicit drug use; 3. Mortality amongst illicit drug users; 4. Mortality and drug overdose; 5. Illicit drug use and disease; 6. Mortality and suicide; 7. Mortality and trauma; 8. Reducing drug-related mortality; 9. Summary and conclusions.
© 2024 LAVOISIER S.A.S.